Dr. Flis was a graduate scholar in the NIH Comparative Biomedical Scientist Training Program in partnership with North Carolina State University and the National Cancer Institute, 2017 –2023.
Prior to joining the program, Dr. Flis received her D.V.M in May of 2017 from Purdue University. She completed her diagnostic pathology training and didactic graduate coursework at North Carolina State University in Raleigh, NC. She then completed her dissertation research in the NCI Laboratory of Human Carcinogenesis under the mentorship of Bríd M. Ryan and Stefan Ambs. Her research focused on characterizing the antiproliferative signaling mechanisms of dopamine receptor D1 (DRD1) in lung cancer cells and investigating those mechanisms’ synergy with EGFR inhibition by small molecules. She received the Society of Toxicologic Pathology Resident and Student Poster Award in 2022 for her poster presentation titled “Investigating the Interactions of Dopamine Receptor D1 in Lung Cancer.”
Members of her graduate committee included: Bríd M. Ryan PhD MPH, Stefan Ambs PhD MPH, R. Mark Simpson DVM PhD DACVP, John Cullen DVM PhD DACVP, Michael W. Nolan DVM PhD DACVR, and committee head Philip L. Sannes PhD.
Dr. Flis is now an investigative pathologist with Sanofi in Cambridge, MA.
